KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Tax Provisions (2021 - 2025)

Historic Tax Provisions for Pacific Biosciences Of California (PACB) over the last 4 years, with Q3 2025 value amounting to $383000.0.

  • Pacific Biosciences Of California's Tax Provisions changed N/A to $383000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $432000.0, marking a year-over-year increase of 16016.71%. This contributed to the annual value of $316000.0 for FY2024, which is 10276.61% up from last year.
  • Pacific Biosciences Of California's Tax Provisions amounted to $383000.0 in Q3 2025.
  • Pacific Biosciences Of California's 5-year Tax Provisions high stood at $1.2 million for Q4 2021, and its period low was -$94.8 million during Q3 2021.
  • Over the past 4 years, Pacific Biosciences Of California's median Tax Provisions value was -$133500.0 (recorded in 2025), while the average stood at -$13.1 million.
  • Data for Pacific Biosciences Of California's Tax Provisions shows a peak YoY increase of 14401.11% (in 2024) and a maximum YoY decrease of 14401.11% (in 2024) over the last 5 years.
  • Over the past 4 years, Pacific Biosciences Of California's Tax Provisions (Quarter) stood at $1.2 million in 2021, then crashed by 161.11% to -$718000.0 in 2023, then surged by 144.01% to $316000.0 in 2024, then grew by 21.2% to $383000.0 in 2025.
  • Its last three reported values are $383000.0 in Q3 2025, $35000.0 for Q2 2025, and -$302000.0 during Q1 2025.